Crispr Therapeutics Price Target Maintained With a $80.00/Share by Citizens
Dow Jones Newswires
Crispr Therapeutics Price Target Maintained With a $80.00/Share by Citizens
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:CRSP
- Language
- English